A detailed history of Baird Financial Group, Inc. transactions in Becton Dickinson & CO stock. As of the latest transaction made, Baird Financial Group, Inc. holds 109,297 shares of BDX stock, worth $24.9 Million. This represents 0.05% of its overall portfolio holdings.

Number of Shares
109,297
Previous 102,175 6.97%
Holding current value
$24.9 Million
Previous $23.9 Million 10.35%
% of portfolio
0.05%
Previous 0.05%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$221.47 - $242.41 $1.58 Million - $1.73 Million
7,122 Added 6.97%
109,297 $26.4 Million
Q2 2024

Aug 13, 2024

SELL
$225.07 - $246.17 $256,354 - $280,387
-1,139 Reduced 1.1%
102,175 $23.9 Million
Q1 2024

May 14, 2024

BUY
$233.45 - $247.73 $3.04 Million - $3.23 Million
13,036 Added 14.44%
103,314 $25.6 Million
Q4 2023

Feb 14, 2024

SELL
$232.24 - $267.23 $4.71 Million - $5.42 Million
-20,281 Reduced 18.34%
90,278 $22 Million
Q3 2023

Nov 13, 2023

BUY
$254.9 - $283.59 $673,445 - $749,244
2,642 Added 2.45%
110,559 $28.6 Million
Q2 2023

Aug 11, 2023

SELL
$238.39 - $265.32 $4.9 Million - $5.45 Million
-20,540 Reduced 15.99%
107,917 $28.5 Million
Q1 2023

May 15, 2023

BUY
$229.71 - $259.35 $2.22 Million - $2.5 Million
9,652 Added 8.12%
128,457 $31.8 Million
Q3 2022

Nov 14, 2022

SELL
$51.03 - $264.23 $204,936 - $1.06 Million
-4,016 Reduced 4.53%
84,658 $18.9 Million
Q2 2022

Aug 08, 2022

SELL
$234.74 - $275.42 $379,105 - $444,803
-1,615 Reduced 1.79%
88,674 $21.9 Million
Q1 2022

May 13, 2022

SELL
$243.64 - $270.48 $1.48 Million - $1.65 Million
-6,083 Reduced 6.31%
90,289 $24 Million
Q4 2021

Feb 09, 2022

BUY
$230.08 - $250.94 $1.6 Million - $1.75 Million
6,972 Added 7.8%
96,372 $24.2 Million
Q3 2021

Nov 12, 2021

BUY
$232.72 - $256.47 $832,904 - $917,906
3,579 Added 4.17%
89,400 $22 Million
Q2 2021

Aug 11, 2021

BUY
$232.65 - $254.58 $1.57 Million - $1.72 Million
6,744 Added 8.53%
85,821 $20.9 Million
Q1 2021

May 13, 2021

BUY
$232.09 - $256.88 $299,164 - $331,118
1,289 Added 1.66%
79,077 $19.2 Million
Q4 2020

Feb 11, 2021

BUY
$221.92 - $245.94 $1.02 Million - $1.14 Million
4,617 Added 6.31%
77,788 $19.5 Million
Q3 2020

Nov 12, 2020

BUY
$215.77 - $276.76 $485,266 - $622,433
2,249 Added 3.17%
73,171 $17 Million
Q2 2020

Oct 22, 2020

SELL
$219.9 - $263.41 $1.2 Million - $1.44 Million
-5,454 Reduced 7.14%
70,922 $17 Million
Q2 2020

Aug 14, 2020

BUY
$219.9 - $263.41 $4.73 Million - $5.67 Million
21,520 Added 39.23%
76,376 $20.7 Million
Q1 2020

May 14, 2020

SELL
$195.69 - $279.01 $4.43 Million - $6.31 Million
-22,614 Reduced 29.19%
54,856 $12.6 Million
Q4 2019

Feb 14, 2020

BUY
$236.45 - $266.82 $1.16 Million - $1.31 Million
4,908 Added 6.76%
77,470 $21.1 Million
Q3 2019

Nov 14, 2019

BUY
$230.58 - $256.08 $921,628 - $1.02 Million
3,997 Added 5.83%
72,562 $18.4 Million
Q2 2019

Aug 14, 2019

BUY
$217.4 - $246.08 $1.2 Million - $1.36 Million
5,525 Added 8.76%
68,565 $17.3 Million
Q1 2019

May 14, 2019

BUY
$206.05 - $248.17 $25,756 - $31,021
125 Added 0.2%
63,040 $15.7 Million
Q4 2018

Feb 14, 2019

BUY
$204.73 - $257.93 $223,974 - $282,175
1,094 Added 1.77%
62,915 $14.2 Million
Q3 2018

Nov 13, 2018

BUY
$233.07 - $256.0 $155,923 - $171,264
669 Added 1.09%
61,821 $16.3 Million
Q2 2018

Aug 13, 2018

BUY
$208.1 - $233.85 $81,783 - $91,903
393 Added 0.65%
61,152 $14.7 Million
Q1 2018

May 14, 2018

BUY
$205.46 - $240.27 $1.71 Million - $2 Million
8,330 Added 15.89%
60,759 $13.2 Million
Q4 2017

Feb 09, 2018

BUY
$189.0 - $222.64 $3.42 Million - $4.03 Million
18,084 Added 52.65%
52,429 $11.2 Million
Q3 2017

Nov 14, 2017

SELL
$186.89 - $198.9 $214,923 - $228,735
-1,150 Reduced 3.24%
34,345 $6.73 Million
Q2 2017

Aug 14, 2017

BUY
N/A
35,495
35,495 $6.93 Million

Others Institutions Holding BDX

About BECTON DICKINSON & CO


  • Ticker BDX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 285,195,008
  • Market Cap $65.1B
  • Description
  • Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide. The company's BD Medical segment offers peripheral intravenou...
More about BDX
Track This Portfolio

Track Baird Financial Group, Inc. Portfolio

Follow Baird Financial Group, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Baird Financial Group, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Baird Financial Group, Inc. with notifications on news.